Genetic variation and phylogenetic analyses of the ORF5 gene of acute porcine reproductive and respiratory syndrome virus isolates

Swine herds in the US have experienced recent outbreaks of a severe form of porcine reproductive and respiratory syndrome (designated acute or atypical PRRS) characterized by abortion and high mortality in pregnant sows. Most of the affected herds had been vaccinated with modified live-vaccines (MLVs) against PRRS. To explore the possible mechanism of the emergence of acute PRRS, the open reading frame 5 (ORF5) gene encoding the major envelope protein (GP5) of acute PRRSV isolates was characterized. The complete ORF5 gene of eight acute PRRSV isolates from herds experiencing acute PRRS outbreaks in Iowa and North Carolina was amplified and sequenced. Sequence analyses revealed that these acute PRRSV isolates shared 88-95% nucleotide and 88-96% amino acid sequence identities to each other, 87-97% nucleotide and 84-96% amino acid sequence identities with other North American PRRSV isolates and the MLVs. Most of the amino acid substitutions locate in the putative signal sequence and two short hypervariable regions at the amino terminus. The ORF5 gene sequence of the acute PRRSV isolate 98-37120-2 from a non-vaccinated swine herd in Iowa is very closely related to that of the RespPRRS MLV, with 97% nucleotide and 96% amino acid sequence identities. Phylogenetic analysis revealed that all eight acute PRRSV isolates are clustered within the North American genotype. Several minor branches that are not associated with geographic origins were also identified within the North American genotype. One acute PRRSV isolate (98-37120-2) is clustered with the RespPRRS MLV and several Danish isolates that were confirmed to be derived from the RespPRRS MLV. The ORF5 gene sequences of other seven acute isolates are more related to those of several earlier PRRSV isolates and the PrimePac MLV than to that of the RespPRRS MLV. Our results showed that the acute PRRSV isolates analyzed in this study differed from each other in ORF5 genes, although they all clustered within the North American genotype. The data from this study do not fully support the hypothesis that the emergence of acute PRRS is due to reversion of MLVs to a pathogenic phenotype, as only one of the eight acute isolates was shown to be very closely related to the RespPRRS MLV.     

Genetic analysis of ORF5 of recent Korean porcine reproductive and respiratory syndrome viruses (PRRSVs) in viremic sera collected from MLV-vaccinating or non-vaccinating farms

The 23 open reading frame (ORF) 5 sequences of Korean type II porcine reproductive and respiratory syndrome virus (PRRSV) were collected from viremic sera from the (modified live vaccine) MLV-vaccinating and non-vaccinating farms from 2007 to 2008. The samples were phylogenetically analyzed with previous ORF5 sequences, including type I Korean PRRSV, and previously reported or collected sequences from 1997 to 2008. A MN184-like subgroup of type II Korean PRRSV was newly identified in the viremic sera collected from 2007 to 2008. And of the type I PRRSVs, one subgroup had 87.2~88.9% similarity with the Lelystad virus, showing a close relationship with the 27~2003 strain of Spain. The maximum parsimony tree of type II PRRSV from 1997 to 2008 showed that they had evolved to four lineages, subgroups 1, 2, 3 and 4. Most of the recently collected type II PRRSVs belonged to subgroup 4 (48%). The region of three B-cell epitopes and two T-cell epitopes of ORF5 amino acids sequences was considerably different from the MLV in subgroups 3 and 4. In conclusion, the existence of type I PRRSV, which was genetically different from Lelystad virus (Prototype of type I PRRSV), and heterologous type II PRRSVs of viremic pigs detected even in the MLV-vaccinating farms indicated the need for new vaccine approaches for the control of PRRSV in Korea.     

A survey of porcine reproductive and respiratory syndrome among wild boar populations in Korea

No information is currently available on porcine reproductive and respiratory syndrome virus (PRRSV) infection in wild boars (Sus scrofa) in Korea. In this study, the status of PRRS in wild boars was investigated. Blood samples were collected from 267 wild boars from eight provinces in Korea. Four of the samples tested (1.5%) were positive for PRRSV antibodies and eight (3.0%) were positive for antigens. Of the virus-positive samples, three and five samples were typed as containing European (EU, type 1) or North American (NA, type 2) viruses, respectively. Two amplicons (one from type 1 and one from type 2) were used to analyze the PRRSV open reading frame 7 (ORF7) sequence. The nucleotide sequences of type 1 PRRSV ORF7 had identities between 96.1% and 98.4% with PRRSVs from domestic pigs in Korea. The sequences of type 2 PRRSV ORF7 had identities of 100% with the PRRSV strain VR-2332, which was prototypic North American strain. These results show that PRRSVs are present in wild boars in Korea, and effective PRRSV surveillance of the wild boar population might therefore be useful for disease control.     

猪繁殖与呼吸综合征病毒山西分离株ORF5基因的序列分析

采用RT-PCR方法对2009—2011年山西省疑似猪繁殖与呼吸综合征(PRRS)阳性病料进行克隆和测序,获得5个ORF5基因片段,并对其基因序列和推导的氨基酸序列与国内外毒株进行了同源性分析。序列分析结果表明,5个ORF5基因序列之间核苷酸同源性为97.7%～98.5%,与欧洲型代表株LV、美洲型代表株VR-2332、2006—2007年国内分离的PRRSV变异株(JXA1、HuN、HUN4、HUB1)、2006年以前中国分离毒株(CH-1a、HB-1(sh)、HB-2(sh))和2个疫苗株(Resp PRRS MLV、MLV RespPRRS/Repro)核苷酸同源性分别为63.5%～64.0%、88.7%～89.2%、97.7%～99.3%、88.1%～96.7%和88.6%～89.1%;氨基酸同源性分别为56.1%～56.6%、87.8%～88.8%、96.6%～98.5%、85.9%～93.2%、86.8%～87.9%。结果表明山西地区的PRRSV流行毒株均属于美洲型,且毒株同源性很高,亲缘关系紧密。     

Comparative evaluation of PRRS virus infection in vaccinated and naïve pigs

The purpose of this study was to evaluate the time-course of the immune response to a field Porcine Respiratory and Reproductive Syndrome virus (PRRSV) strain in PRRS-naïve, untreated pigs, as well as in four groups of age and breed-matched pigs injected with a live attenuated PRRS vaccine, its adjuvant, an inactivated PRRS vaccine and an irrelevant, inactivated Porcine Circovirus type 2 (PCV2) vaccine, respectively. PRRSV infection was confirmed in all groups by PCR and antibody assays. The antibody response measured by ELISA took place earlier in pigs injected with the live attenuated vaccine, which also developed a much stronger serum-neutralizing antibody response to the vaccine strain. Yet, no clear protection was evidenced in terms of viremia against the field virus strain, which showed 11.1% nucleotide divergence in ORF7 from the vaccine strain. In vitro, the interferon (IFN)-γ response to PRRSV was almost absent on PVD 60 in all groups under study, whereas the prevalence of interleukin (IL)-10 responses to PRRSV was fairly high in PCV2-vaccinated animals, only. Results indicate that distinct patterns of immune response to a field PRRSV strain can be recognized in PRRS-vaccinated and naïve pigs, which probably underlies fundamental differences in the development and differentiation of PRRSV-specific immune effector cells.     

Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus

Various vaccine adjuvant candidates were assessed with the modified-live porcine reproductive and respiratory syndrome virus (MLV PRRSV) (Ingelvac PRRS MLV) vaccine. Their influence on humoral-mediated immune (HMI) and cell-mediated immune (CMI) responses as well as protection from virulent PRRSV challenge (MN-184) was evaluated. Ninety seronegative pigs were randomly divided into nine groups of 10 pigs. One group received MLV vaccine alone. Five groups received MLV vaccine with either bacterial endotoxin-derived adjuvant (ET), mixed open reading frame 5 (ORF5) peptides derived from various PRRSV isolates, porcine interferon alpha (IFNalpha), polyinosinic-polycytidylic acid stabilized with polylysine and carboxymethylcellulose (poly-ICLC), or porcine interleukin-12 (IL-12). One group did not receive MLV vaccine but was immunized with ORF5 peptides conjugated with cholera toxin (ORF5 peptide/CT). Two groups served as challenged and unchallenged non-vaccinated controls. Four-color flow cytometry was utilized to simultaneously identify three major porcine T-cell surface markers (CD4, CD8, and gammadelta TCR) and detect activation marker CD25 (alpha chain of IL-2 receptor) or intracellular IFNgamma. The MLV PRRSV vaccine alone successfully primed CD4(-)CD8(+)gammadelta- T-cells as demonstrated by a significant increase in %IFNgamma+ cells when live PRRSV was used as a recall antigen. Booster immunizations of mixed ORF5 peptides and co-administration of IL-12 with MLV PRRSV vaccine significantly enhanced IFNgamma expression by some T-cell subsets (CD4(-)CD8(+)gammadelta+ and CD4(-)CD8(-)gammadelta+ for mixed ORF5 peptides and CD4(+)CD8(+)gammadelta- and CD4(-)CD8(+)gammadelta+ for IL-12). All groups receiving MLV-vaccine with or without adjuvants had reduced lung lesions after challenge. The group immunized with only ORF5 peptide/CT did not have significant T-cell recall responses and was not protected from challenge. Expression of IFNgamma by several T-cell subsets correlated with reduced lung lesions and viremia, whereas expression of CD25 did not. Expression of surface CD25 did not correlate with IFNgamma production. PRRSV ELISA s/p ratio prior to challenge also correlated with reduced lung lesions and viremia. In conclusion, booster immunizations of the mixed ORF5 peptides and co-administration of IL-12 effectively enhanced the CMI response to MLV vaccine. However, neither adjuvant significantly contributed to reducing clinical effects when compared to MLV alone.     

Significance of genetic variation of PRRSV ORF5 in virus neutralization and molecular determinants corresponding to cross neutralization among PRRS viruses

A high rate of genetic and antigenic variability among porcine reproductive and respiratory syndrome viruses (PRRSVs) hampers effective prevention and control of the disease caused by PRRSV. The major envelope protein (GP5) encoded by the ORF5 of PRRSV has a critical role in inducing virus neutralizing (VN) antibody and cross protection among different strains of PRRSV. This study was conducted to identify sequence elements related to cross neutralization by comparing the ORF5 sequences of 69 field isolates in conjunction with their susceptibility to VN antibody raised against the VR2332 strain in vitro and in vivo. Five common variable sites (amino acid position 32–34, 38–39, 57–59, 137 and 151) were identified between susceptible and resistant viral isolates. Mutants whose ORF5 amino acid sequences were substituted with the sequences corresponding to the 5 identified common variable sites individually or concurrently were generated from a VR2332-backboned infectious clone by site mutagenesis. The change in the susceptibility of the mutants to VN antibodies specific for VR2332 or a heterologous PRRSV was assessed to determine the association of those 5 identified sites with cross neutralization. Among the five sites, the changes of amino acid sequences at three sites (32–34, 38–39, and 57–59) located in the N-terminal ectodomain of ORF5 significantly influenced the susceptibility of the mutant viruses to VN antibody, suggesting that sequence homology at these sites can be utilized as genetic markers to predict the degree of cross neutralization among different PRRSVs.     

猪繁殖与呼吸综合征病毒HS株结构蛋白基因的克隆与序列分析

根据GenBank中猪繁殖与呼吸综合征病毒(PRRSV)美洲株(VR-2332)基因序列,设计合成了ORF2a、ORF3、ORF4、ORF5、ORF6和ORF7基因的引物.利用RT-PCR扩增出PRRSV HS株各基因的cDNA片段,将扩增的各cDNA片段克隆入pMD18-T载体并测序.应用DNA Man软件,将测序结果与国内外已发表野毒株和疫苗株(VR-2332、Resp MLV、16244B、HN1、BJ-4、CH1-a、HB-1、HB-2、LV)的相应基因进行序列比较,并绘制系统进化树.结果表明,PRRSV HS株与美洲型的相应基因核苷酸同源性为83.6%～99.7%,与LV株的相应基因核苷酸同源性为38.9%～49%;推导的氨基酸与美洲型相应基因的同源性为86.6%～99.6%,与LV株的同源性为54.2%～78.2%.系统进化树表明,PRRSV HS株属于美洲型,与HN1、VR-2332、RespMLV、16244B、BJ-4亲缘关系较近.     

猪繁殖与呼吸综合征病毒ORF7基因原核表达载体的构建及序列分析

根据GenBank中美洲型猪繁殖与呼吸综合征病毒(PRRSV)ORF7基因序列,设计合成一对引物,应用RT-PCR方法扩增出猪繁殖与呼吸综合征病毒(PRRSV)的ORF7基因(N基因)。将所扩增片段克隆入原核表达载体pET-32a(+),pET-ORF7重组质粒转化DH5a宿主菌后,经双酶切、PCR鉴定后挑选阳性克隆测序鉴定并对插入的ORF7基因序列进行分析。结果表明,ORF7基因的原核表达载体构建成功。ORF7基因序列与美洲型的ORF7基因核苷酸同源性为92.8%～99.7%,与LV株的相应基因核苷酸同源性为65.3%;推导的氨基酸与美洲型相应基因的同源性为92.0%～99.2%,与LV株的同源性为65.3%,系统进化树表明该PRRSV属于美洲型。本研究为N蛋白的进一步研究和制备诊断性抗原奠定了基础。     

2018年广东部分地区猪繁殖与呼吸综合征病毒流行毒株ORF5基因变异分析

为了解广东省猪繁殖与呼吸综合征病毒(PRRSV)流行毒株ORF5基因遗传变异情况,采用RT-PCR对2018年采自广东部分地区疑似患有PRRS的猪肺组织样品进行PRRSV ORF5基因扩增以及克隆测序,并进行生物信息学分析。结果表明,成功扩增出18株PRRSV流行毒株的ORF5基因片段。ORF5基因序列分析表明,18株PRRSV流行毒株ORF5基因核苷酸同源性为83.7%~99.8%,PRRSV流行毒株与参考毒株的同源性为62.1%~99.8%。基于ORF5基因的遗传进化树分析表明,18株PRRSV流行株均为美洲型毒株。其中,10株与以JXA1为代表的高致病性毒株亲缘较近,2株与新型高致病性毒株FZ16A相似;1株与以NT1为代表的疫苗返强毒株亲缘较近,1株与以R98为代表的疫苗毒株亲缘性较近,4株与广东新报道的GM2和QYYZ毒株亲缘性较近。DNA推导氨基酸序列分析表明,18株流行株的氨基酸序列与国内已报道的代表株相比发生不同程度的变异,GP5抗原表位上存在着差异。研究结果揭示了广东地区PRRSV有新型强毒株、重组毒株以及疫苗返强毒株的流行,提示养殖者谨慎、合理使用疫苗,防止疫苗毒株返强和毒株重组,为该地区防控PRRS提供参考。     

Construction and evaluation of genetically engineered replication-defective porcine reproductive and respiratory syndrome virus vaccine candidates

Porcine reproductive and respiratory syndrome virus (PRRSV) is an emerging pathogen causing significant economic losses in the swine industry worldwide. Two novel gene-deleted viruses were constructed and evaluated as vaccine candidates. Using the full-length infectious cDNA clone of North American PRRS isolate P129, the ORF2 and ORF4 genes (which encoded minor structural glycoproteins GP2a/2b and GP4, respectively) were individually deleted from the viral genome. Both deletion mutants were non-viable in MARC-145 cells and porcine alveolar macrophages, indicating that both genes are essential for virus replication. To rescue the replication-defective PRRSV, two complementing cell lines, MARC-2000 and MARC-400, were established to stably express the PRRSV GP2 and GP4 proteins, respectively. These cells were able to complement the deleted gene function of PRRSV in trans and supported production of the replication-defective DeltaORF2-PRRSV and DeltaORF4-PRRSV viruses. Both DeltaORF2-PRRSV and DeltaORF4-PRRSV viruses were propagated for 40-50 generations in the corresponding complementing cells and remained replication-defective in MARC-145 cells. To examine the immunogenic potential of the replication-defective PRRSV as vaccine candidates, four groups of pigs, 20 pigs per group, were immunized twice with DeltaORF2-PRRSV or DeltaORF4-PRRSV and challenged with the homologous virulent virus at 3 weeks post-immunization. In spite of the fact one group showed significant reduction in virus load, we could not demonstrate improvement from clinical diseases in this vaccination/challenge study. However, we did show that the cDNA clone of PRRSV can be a useful tool to genetically engineer PRRSV vaccine candidates and to study pathogenesis and viral gene functions.     

2007-2010年江苏地区猪繁殖与呼吸综合征病毒RT-PCR检测及部分Nsp2基因序列分析

本研究参考GenBank已发表的猪繁殖与呼吸综合征病毒（Porcine reproductive and respiratory syndrome virus,PRRSV）Nsp2基因序列,在高致病性病毒Nsp2基因缺失区的两端保守区设计并合成了一对引物,建立并优化了能够区分经典PRRSV和高致病性PRRSV的RT-PCR诊断方法,并利用该方法对2007～2010年间江苏地区的45份可疑临床病料进行了检测。结果表明临床病料阳性率为40％,所有毒株均属于高致病性毒株。对PRRSV阳性病毒的Nsp2基因序列分析表明,所有18株PRRSV均属于美洲型毒株,与中国高致病性PRRSV代表毒株JXA1、WUH1的氨基酸同源性分别在82．2％～97．6％、80．4％～95.3％。此外,18株病毒的Nsp2共同存在不连续的30个氨基酸缺失,缺失位置与同期中国高致病性PRRSV具有相同的特征。通过本研究掌握了江苏地区2007～2010年间PRRSV流行情况及Nsp2基因变异特征,为地方猪繁殖与呼吸综合征的临床诊断和防治提供参考依据。     

A transgenic Marc-145 cell line of piggyBac transposon-derived targeting shRNA interference against porcine reproductive and respiratory syndrome virus

Porcine reproductive and respiratory syndrome (PRRS) is now considered to be one of the most important diseases in countries with intensive swine industries. The two major membrane-associated proteins of porcine reproductive and respiratory syndrome virus (PRRSV), GP5 and M (encoded by ORF5 and ORF6 genes, respectively), are associated as disulfide-linked heterodimers (GP5/M) in the virus particle. In this study, we designed 5 of the small hairpin RNAs (shRNAs) targeting the GP5 and M gene of PRRSV respectively, and investigated their inhibition to the production of PRRSV. The highest activity displayed in shRNAs of the ORF6e sequence (nts 261-279), which the inhibition rate reached was 99.09%. The result suggests that RNAi technology might serve as a potential molecular strategy for PRRSV therapy. Furthermore, the transgenic Marc-145 cell line of piggyBac transposon-derived targeting shRNA interference against PRRS virus was established. It presented stable inhibition to the replication and amplification of PRRS. The work implied that shRNAs targeting the GP5 and M gene of PRRSV may be used as potential RNA vaccines in vivo, and supplied the screening methods of transformed pig embryonic fibroblast which are prerequisite for the disease-resistant transgenic pigs to PRRS.     

2016-2017年江西地区猪繁殖与呼吸综合征病毒分子流行病学调查及ORF5基因变异分析

为了解近年来江西地区猪繁殖与呼吸综合征病毒（porcine reproductive and respiratory syndrome virus,PRRSV）分子流行病学和其遗传变异情况,本次调查于2016-2017年从江西省各地区规模化猪场采集453份疑似猪繁殖与呼吸综合征（PRRS）的病料,采用RT-PCR方法对所有病料进行检测。结果发现,其中321份病料为PRRSV阳性,阳性率为70.86%,各地区的阳性率在19.15%~84.85%之间。挑选14份阳性样品测序后,经ORF5基因序列分析,江西地区各PRRSV毒株ORF5基因的核苷酸同源性为83%~100%,PRRSV流行毒株与参考毒株的同源性在59.9%~98.5%之间。基于ORF5基因的进化树分析表明,14个测序毒株均为美洲型毒株,其中有4株为基因亚型Ⅰ,即高致病性毒株（HP-PRRSV）;3株为基因亚型Ⅱ,即经典毒株;3株为基因亚型Ⅲ,即NADC30-like毒株;4株为新出现的基因亚型Ⅳ。氨基酸序列比对分析表明,基因亚型Ⅰ、Ⅱ、Ⅲ和Ⅳ毒株ORF5基因编码的GP5蛋白氨基酸在3个表位及2个重要的抗原相关区域存在较大变异,其中以NADC30毒株为代表的基因亚型Ⅲ毒株和以GD1404毒株为代表的基因亚型Ⅳ毒株均表现出独有的氨基酸变异,这些变异可能会影响GP5蛋白的免疫原性。本次调查结果表明,2016-2017年江西地区PRRSV流行出现了新形势,美洲型毒株出现了多基因亚型共同存在的局面,以高致病性毒株（HP-PRRSV）为主,NADC30-like毒株和新基因亚型等新毒株的比例较高,同时还存在经典毒株;持续实时监测PRRSV的毒株流行和变异情况,可为临床诊断、药物和疫苗开发及PRRS的科学防控提供依据。     

猪繁殖与呼吸综合征病毒TS株结构蛋白基因的克隆与变异分析

从河北唐山分离到一株疑似猪繁殖与呼吸综合征病毒(PRRSV),接种Marc-145细胞,经2代盲传后出现细胞病变,经鉴定为PRRSV,命名为TS株。利用RT-PCR扩增出TS株各基因的cDNA片段,然后克隆入pMD19-T载体并测序。应用DNAStar软件,结合其它河北毒株与多株GenBank中已发表的PRRSV毒株相应基因进行序列比较。结果表明:PRRSV TS株与VR-2332同源性为88.9%-94.7%,与河北省2007年以来发现的8个毒株同源性很强,为98.0%-99.7%;与LV株的亲缘关系较远,同源性为61.2%-69.0%,属于美洲型。遗传进化树表明国内美洲型分离株明显分为2个亚群,所有河北省流行毒株属于同一亚群,且TS株与高致病性代表毒株JXA1关系非常近。本研究将为河北省预防和控制PRRS提供重要的理论数据。     

Antibody and cellular immune responses of swine following immunisation with plasmid DNA encoding the PRRS virus ORF's 4, 5, 6 and 7.

The objectives of this study was to investigate the role of DNA vaccines in the generation of an immune response and that elicited against individually encoded proteins of PRRSV. The genomic regions encoding ORF s 4, 5, 6 and 7 of the PRRS virus vaccine strain were cloned into the mammalian expression vector pc DNA 3.1 (+). Inoculations with the recombinant plasmids resulted in detection of PRRS virus-specific antibodies in 71 per cent of the immunized animals by ELISA, virus neutralization and/or Western blotting assays. In addition, cellular immune responses were detected in 86 per cent of the immunized pigs by interferon gamma assay and/or proliferation assay. Pigs in the control group had no detectable immune response to PRRS virus. The results obtained demonstrated that DNA immunization against PRRS virus results in the production of both humoral and cell mediated immune responses in pigs. The results also indicate that neutralization epitopes for PRRS virus are present on the viral envelope glycoproteins encoded by ORF 4 and ORF 5.     

Efficacy of Fostera PRRS modified live virus vaccine against a Canadian heterologous virulent field strain of porcine reproductive and respiratory syndrome virus

Vaccination is a useful option to control infection with porcine reproductive and respiratory syndrome virus (PRRSV), and several modified live-PRRSV vaccines have been developed. These vaccines have shown some efficacy in reducing the incidence and severity of clinical disease as well as the duration of viremia and virus shedding but have failed to provide sterilizing immunity. The efficacy of modified live-virus (MLV) vaccines is greater against a homologous strain compared with heterologous PRRSV strains. The objective of this study was to evaluate the efficacy of Fostera PRRS MLV vaccine in protecting against challenge with a heterologous field strain widely circulating in the swine herds of eastern Canada. Forty-six piglets were divided into 4 groups: nonvaccinated-nonchallenged; nonvaccinated-challenged; vaccinated-challenged; and vaccinated-nonchallenged. The animals were vaccinated at 23 d of age with Fostera PRRS and challenged 23 d later with a heterologous field strain of PRRSV (FMV12-1425619). Overall, the vaccine showed some beneficial effects in the challenged animals by reducing the severity of clinical signs and the viral load. A significant difference between nonvaccinated and vaccinated animals was detected for some parameters starting 11 to 13 d after challenge, which suggested that the cell-mediated immune response or other delayed responses could be more important than pre-existing PRRSV antibodies in vaccinated animals within the context of protection against heterologous strains.     

猪繁殖与呼吸综合征病毒变异株ORF6基因的克隆与原核表达研究

根据GenBank中美洲型猪繁殖与呼吸综合征病毒(PRRSV)的ORF6基因序列,设计合成一对特异性引物,应用RT-PCR方法扩增出PRRSV的ORF6基因(M基因)。将所扩增片段克隆入原核表达载体pET-32a(+),pET-ORF6重组质粒转化DH5a宿主菌后,经双酶切、PCR鉴定后挑选阳性克隆测序鉴定并对插入的ORF6基因序列进行分析。结果表明,ORF6基因的原核表达载体构建成功。ORF6基因推导的氨基酸与美洲型相应基因的同源性为96.0%～100%,与LV株的同源性为79.9%,系统进化树表明该PRRSV属于美洲型。将构建成功的重组质粒pET-ORF6转化BL21,诱导后经SDS-PAGE和Western-blot分析表明:克隆在HIS标签的膜基质蛋白基因与HIS获得了高效表达,表达的融合蛋白HIS-M分子量约为39kDa,并且有免疫学反应活性。